Tag Archives: Blues Plans

Update on Blue Cross Blue Shield Plans 2022 Financial Results

BlueCross Blue Shield Plans: Access Market Intelligence

Blue Cross Blue Shield Plans mid-2022 financial results continue to improve as the pandemic recedes into the past

Blues Plans Can Use Various Tactics to Mitigate Generic Drug Price Inflation

Blues Plans Can Use Various Tactics to Mitigate Generic Drug Price Inflation, Published in The AIS Report on Blue Cross Blue Shield Plans, V14, Number 7 July 2015         Randy Vogenberg, Ph.D., Partner, Access Market Intelligence notes that the FDA has cited “quality and manufacturing issues” as “a major reason for drug shortages. Most […]